COHN Stock Chart & Stats
$2391.38
$0.00(0.00%)
At close: 4:00 PM EDT
$2391.38
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$2,391.38 - $3,238.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$111.36B
Enterprise Value$7.99K
Total Cash (Recent Filing)$187.70M
Total Debt (Recent Filing)$212.70M
Price to Earnings (P/E)60.3
Beta-0.02
Next Earnings
Feb 16, 2027EPS Estimate
32.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.25
Shares Outstanding65,398,920
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.87
Price to Book (P/B)4.58
Price to Sales (P/S)3.41
P/FCF Ratio25.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,717.68Price Target Upside-28.17% Downside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)63.86
Revenue Forecast (FY)$29.23B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage gives Cochlear financial flexibility to fund research, product launches and capital investment without relying heavily on debt. This supports resilience through reimbursement delays, regional weakness or temporary earnings pressure.
Installed-Base Services GrowthThe large installed base creates recurring upgrade and aftercare opportunities beyond initial implant sales. Strong services growth and processor replacement activity can improve revenue visibility and deepen long-term customer relationships.
Product Innovation And PipelineSustained R&D investment supports Cochlear's technology leadership and creates avenues for future category growth. Regulatory progress for Osia and TICI expands the product pipeline and may strengthen competitiveness over several years.
Bears Say
Margin And Profitability CompressionThe sharp earnings decline shows that strong gross profitability is not currently translating into stable bottom-line returns. Flat margin guidance and a 14% underlying net margin, versus an 18% target, indicate a potentially prolonged recovery.
Regional Pricing And Reimbursement PressureHealthcare capacity constraints, reimbursement changes and China pricing rules are limiting procedure access or reducing realized prices. These pressures can persist across planning cycles and weigh on growth, mix and margins in important markets.
Foreign-Exchange Earnings ExposureCochlear's international revenue base exposes reported earnings to currency movements even with hedging. The stated sensitivity is material, making profit delivery less predictable and potentially delaying progress toward the medium-term margin target.
Cochlear News
COHN FAQ
What was Cochlear Limited’s price range in the past 12 months?
Cochlear Limited lowest stock price was $2391.38 and its highest was $3238.00 in the past 12 months.
What is Cochlear Limited’s market cap?
Cochlear Limited’s market cap is $111.36B.
When is Cochlear Limited’s upcoming earnings report date?
Cochlear Limited’s upcoming earnings report date is Feb 16, 2027 which is in 158 days.
How were Cochlear Limited’s earnings last quarter?
Cochlear Limited released its earnings results on Aug 17, 2026. The company reported $23.761 earnings per share for the quarter, beating the consensus estimate of $20.557 by $3.205.
Is Cochlear Limited overvalued?
According to Wall Street analysts Cochlear Limited’s price is currently Overvalued.
Does Cochlear Limited pay dividends?
Cochlear Limited does not currently pay dividends.
What is Cochlear Limited’s EPS estimate?
Cochlear Limited’s EPS estimate is 32.41.
How many shares outstanding does Cochlear Limited have?
Cochlear Limited has 65,398,920 shares outstanding.
What happened to Cochlear Limited’s price movement after its last earnings report?
Cochlear Limited reported an EPS of $23.761 in its last earnings report, beating expectations of $20.557. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cochlear Limited?
Currently, no hedge funds are holding shares in MX:COHN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cochlear Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1,717.68 (-28.17% Downside)
$1,717.68 (-28.17% Downside)
Blogger Sentiment
Bullish
MX:COHN Sentiment 85%
Sector Average 61%
Sector Average 61%
Insider Transactions
Bought Shares
Worth $5.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.71%
12-Months-Change
Fundamentals
Return on Equity
2.36%
Trailing 12-Months
Asset Growth
-2.60%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cochlear Limited
Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
COHN Company Deck
COHN Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call outlined clear strategic progress: a highly successful Nexa product launch, meaningful unit growth, strong services expansion in developed markets, disciplined cash and cost management, and continued heavy R&D investment into attractive pipeline programs (TICI, drug-eluting electrodes). However, material near-term challenges remain — a 3ppt gross margin decline to 71%, an underlying net profit margin below target (14% vs 18% medium-term goal), Western Europe weakness, China pricing headwinds, non-cash write-downs and FY'27 FX headwinds. Management has responded with cost optimization, targeted growth re-investment (DTC and professional referral pilots) and a conservative FY'27 outlook (low single-digit revenue growth; underlying NP $330m–$350m). Overall the call balanced tangible product and pipeline upside with notable geopolitical, reimbursement and margin pressures.View all MX:COHN earnings summariesCOHN Stock 12 Month Forecast
Average Price Target
$1,717.68
▼(-28.17% Downside)